Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Akero Therapeutics Inc’s stock clocked out at $31.05, up 3.74% from its previous closing price of $29.93. In other words, the price has increased by $3.74 from its previous closing price. On the day, 0.52 million shares were traded. AKRO stock price reached its highest trading level at $31.25 during the session, while it also had its lowest trading level at $29.82.
Ratios:
To gain a deeper understanding of AKRO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 24.89 and its Current Ratio is at 24.89. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
On September 19, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $69.
On August 28, 2023, UBS started tracking the stock assigning a Buy rating and target price of $83.UBS initiated its Buy rating on August 28, 2023, with a $83 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 14 ’24 when Young Jonathan sold 40,000 shares for $30.15 per share. The transaction valued at 1,206,080 led to the insider holds 226,286 shares of the business.
Yale Catriona sold 14,825 shares of AKRO for $452,232 on Oct 15 ’24. The Chief Development Officer now owns 75,294 shares after completing the transaction at $30.50 per share. On Oct 14 ’24, another insider, Yale Catriona, who serves as the Chief Development Officer of the company, sold 6,136 shares for $30.03 each. As a result, the insider received 184,258 and left with 74,158 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKRO now has a Market Capitalization of 2155826176 and an Enterprise Value of 1432238208.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $37.00, while it has fallen to a 52-week low of $11.25. The 50-Day Moving Average of the stock is 14.81%, while the 200-Day Moving Average is calculated to be 28.62%.
Shares Statistics:
It appears that AKRO traded 553.65K shares on average per day over the past three months and 483520 shares per day over the past ten days. A total of 69.43M shares are outstanding, with a floating share count of 58.10M. Insiders hold about 16.32% of the company’s shares, while institutions hold 98.60% stake in the company. Shares short for AKRO as of 1727654400 were 6766665 with a Short Ratio of 12.22, compared to 1724976000 on 7111377. Therefore, it implies a Short% of Shares Outstanding of 6766665 and a Short% of Float of 10.040000000000001.
